Rose‐Laure Indorato

Author

Rose‐Laure Indorato

Also Known As

Indorato, R-L, R. L. Indorato, Rosalba Indorato, Rose-Laure Indorato, Rose‐Laure Indorato

Publications

245

Citations

H-Index

Concepts

All Affiliations

Rose‐Laure Indorato is an author at Institut de Biologie Structurale specializing in engineering, drug discovery, and signal transduction.

#	Concept	H-Index	Publications	Citations
1	Engineering	1	1	11
2	Medicine	1	1	11
3	Biomolecular Engineering	1	1	11
4	Cell Biology	1	1	11
5	Drug Discovery	1	1	11

Rose‐Laure Indorato

Publications

212

Citations

H-Index

Page 1

	Year	Citations
Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed Dimitrios A. Skoufias, Rose‐Laure Indorato, Françoise Lacroix, The Journal of Cell Biology	2007	94
Structure–Activity Relationship of <i>S</i>-Trityl-<scp>l</scp>-Cysteine Analogues as Inhibitors of the Human Mitotic Kinesin Eg5 Salvatore DeBonis, Dimitrios A. Skoufias, Rose‐Laure Indorato, Journal of Medicinal Chemistry	2008	63
Proteome analysis of apoptosis signaling by <b><i>S</i></b>‐trityl‐<scp>L</scp>‐cysteine, a potent reversible inhibitor of human mitotic kinesin Eg5 Frank Kozielski, Dimitrios A. Skoufias, Rose‐Laure Indorato, PROTEOMICS	2008	28
Is the Fate of Clinical Candidate Arry-520 Already Sealed? Predicting Resistance in Eg5–Inhibitor Complexes Rose‐Laure Indorato, Sandeep K. Talapatra, Fangzhu Lin, Molecular Cancer Therapeutics	2019	16
STLC-resistant cell lines as tools to classify chemically divergent Eg5 targeting agents according to their mode of action and target specificity Rose‐Laure Indorato, Salvatore DeBonis, Frank Kozielski, Biochemical Pharmacology Drug TargetSignal TransductionDivergent Eg5EngineeringDrug Discovery	2013	11

Page 1